StockGlow

Sorrento Therapeutics, Inc. (SRNE)

Develops cancer and viral disease treatments using cell therapy and antibody drugs.

$0.00-0.60%Healthcare
Compare SRNE with
StockGlow Score
3
Bearish
BearishBullish
1 year ago-73.3%

The outlook

SRNE is trading near its 52-week low with price well below both its 50- and 200-day moving averages, reflecting sustained downward pressure. Analyst coverage appears minimal or unavailable in the data provided. The overall sentiment leans heavily bearish based on current technical positioning.

What’s behind the score

Price trendBelow its 50- & 200-day averages
52-week range0% of the way from its 52-week low to high
Market cap
$220,512
52-wk high
$0.10
52-wk low
$0.00
50-day avg
$0.00
200-day avg
$0.00
Trailing P/E
—

Similar stocks

VXRTVaxart, Inc.$0.48+6.64%INOInovio Pharmaceuticals, Inc.$1.03+6.72%IBIOiBio, Inc.$1.39-4.14%NVAXNovavax, Inc.$7.37-1.60%CODXCo-Diagnostics, Inc.$1.41-30.88%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy